These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 1984898)

  • 1. Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group.
    Goldstein RE; Boccuzzi SJ; Cruess D; Nattel S
    Circulation; 1991 Jan; 83(1):52-60. PubMed ID: 1984898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of diltiazem and verapamil on mortality and cardiac events in non-Q-wave acute myocardial infarction without pulmonary congestion: post hoc subset analysis of the multicenter diltiazem postinfarction trial and the second danish verapamil infarction trial studies.
    Gibson RS; Hansen JF; Messerli F; Schechtman KB; Boden WE
    Am J Cardiol; 2000 Aug; 86(3):275-9. PubMed ID: 10922432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction between diltiazem and left ventricular function after myocardial infarction. Multicenter Diltiazem Post-Infarction Research Group.
    Moss AJ; Oakes D; Benhorin J; Carleen E
    Circulation; 1989 Dec; 80(6 Suppl):IV102-6. PubMed ID: 2688978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between beta-adrenergic blocker use, various correlates of left ventricular function and the chance of developing congestive heart failure. The Multicenter Diltiazem Post-Infarction Research Group.
    Lichstein E; Hager WD; Gregory JJ; Fleiss JL; Rolnitzky LM; Bigger JT
    J Am Coll Cardiol; 1990 Nov; 16(6):1327-32. PubMed ID: 1977779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of diltiazem on long-term outcome after acute myocardial infarction in patients with and without a history of systemic hypertension. The Multicenter Diltiazem Postinfarction Trial Research Group.
    Moss AJ; Oakes D; Rubison M; McDermott M; Carleen E; Eberly S; Brown M
    Am J Cardiol; 1991 Aug; 68(5):429-33. PubMed ID: 1872266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis after hospitalization for acute myocardial infarction not accompanied by typical ischemic chest pain. The Multicenter Diltiazem Postinfarction Trial Research Group.
    Goldstein RE; Boccuzzi SJ; Cruess D
    Am J Med; 1995 Aug; 99(2):123-31. PubMed ID: 7625416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrocardiographic subset analysis of diltiazem administration on long-term outcome after acute myocardial infarction. The Multicenter Diltiazem Post-Infarction Trial Research Group.
    Boden WE; Krone RJ; Kleiger RE; Oakes D; Greenberg H; Dwyer EJ; Miller JP; Abrams J; Coromilas J; Goldstein R
    Am J Cardiol; 1991 Feb; 67(5):335-42. PubMed ID: 1994656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin E increases the risk of developing heart failure after myocardial infarction: Results from the GISSI-Prevenzione trial.
    Marchioli R; Levantesi G; Macchia A; Marfisi RM; Nicolosi GL; Tavazzi L; Tognoni G; Valagussa F;
    J Cardiovasc Med (Hagerstown); 2006 May; 7(5):347-50. PubMed ID: 16645413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of diltiazem on recurrent myocardial infarction in patients with non-Q wave myocardial infarction.
    Wong SC; Greenberg H; Hager WD; Dwyer EM
    J Am Coll Cardiol; 1992 Jun; 19(7):1421-5. PubMed ID: 1593034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of diltiazem on cardiac function assessed by echocardiography and neurohumoral factors after reperfused myocardial infarction without congestive heart failure.
    Maki N; Yoshiyama M; Omura T; Yoshimura T; Kawarabayashi T; Sakamoto K; Hirota K; Iida H; Takeuchi K; Yoshikawa J
    Cardiovasc Drugs Ther; 2001 Nov; 15(6):493-9. PubMed ID: 11916358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial.
    Gibson RS; Boden WE; Theroux P; Strauss HD; Pratt CM; Gheorghiade M; Capone RJ; Crawford MH; Schlant RC; Kleiger RE
    N Engl J Med; 1986 Aug; 315(7):423-9. PubMed ID: 3526151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of reinfarction subsequent to non-Q-wave infarction.
    Roberts R; Gibson RS
    J Cardiovasc Pharmacol; 1989; 13 Suppl 1():S36-46. PubMed ID: 2468975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of diltiazem on mortality and reinfarction after myocardial infarction.
    Multicenter Diltiazem Postinfarction Trial Research Group
    N Engl J Med; 1988 Aug; 319(7):385-92. PubMed ID: 2899840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congestive heart failure and ejection fraction in acute myocardial infarction.
    Mangschau A; Rollag A; Jonsbu J; Lund Karlsen R
    Acta Med Scand; 1986; 220(2):101-7. PubMed ID: 3776685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants and significance of diltiazem plasma concentrations after acute myocardial infarction. The Multicenter Diltiazem Postinfarction Trial Research Group.
    Nattel S; Talajic M; Goldstein RE; McCans J
    Am J Cardiol; 1990 Dec; 66(20):1422-8. PubMed ID: 2251986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of a placebo-controlled clinical trial of long-acting diltiazem and aspirin versus aspirin alone in patients receiving thrombolysis with a first acute myocardial infarction. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis Post-Thrombolysis (diltiazem) (INTERCEPT) Research Group.
    Boden WE; Scheldewaert R; Walters EG; Whitehead A; Coltart DJ; Santoni JP; Belgrave G; Starkey IR
    Am J Cardiol; 1995 Jun; 75(16):1120-3. PubMed ID: 7762497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metoprolol CR/XL in postmyocardial infarction patients with chronic heart failure: experiences from MERIT-HF.
    Jánosi A; Ghali JK; Herlitz J; Czuriga I; Klibaner M; Wikstrand J; Hjalmarson A;
    Am Heart J; 2003 Oct; 146(4):721-8. PubMed ID: 14564329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT).
    Boden WE; van Gilst WH; Scheldewaert RG; Starkey IR; Carlier MF; Julian DG; Whitehead A; Bertrand ME; Col JJ; Pedersen OL; Lie KI; Santoni JP; Fox KM
    Lancet; 2000 May; 355(9217):1751-6. PubMed ID: 10832825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium antagonists in myocardial infarction.
    Zannad F; Sadoul N
    J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S16-9. PubMed ID: 1706009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of diltiazem during myocardial reperfusion: a randomized trial in acute myocardial infarction.
    Pizzetti G; Mailhac A; Li Volsi L; Di Marco F; Lu C; Margonato A; Chierchia SL
    Ital Heart J; 2001 Oct; 2(10):757-65. PubMed ID: 11721720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.